In this study, we use our approach to building a descriptively probabilistic relationship between mutated primary structure of coagulation factor IX
and clinical severity of hemophilia B.
Efficacy and safety of recombinant fusion protein linking coagulation factor IX
with albumin (rIX-FP) in previously treated patients with hemophilia B undergoing major orthopedic surgeries.
IXINITY coagulation factor IX
(recombinant) and any and all Emergent BioSolutions Inc.
examines applications of Coagulation Factor IX
and its consumers
Concentrate recombinant coagulation factor IX
, a minimum of second generation in the number of 60 000 IU
GTC previously obtained from ProGenetics an exclusive license to a number of recombinant plasma proteins, including human coagulation factor IX
, for North America, Europe and Japan.
24, 2013 /PRNewswire/ -- The agreement covers the commercial manufacture of a monoclonal antibody used for the recovery and purification of coagulation factor IX
from human blood.
Biovitrum (STO:BVT) today announced it has entered into a new agreement, effective August 8, 2007, with Wyeth (NYSE:WYE) to co-promote BeneFIX[R], Coagulation Factor IX
(Recombinant) for hemophilia B, in the Nordic countries (Denmark, Finland, Iceland, Norway and Sweden).
20 80 9 33621000-9 Coagulation Factor Ix
1200 Iu Vial with Solvent Vial Factor Ix + 4:16
AMSTERDAM, July 3, 2013 /PRNewswire/ -- Data presented by CSL Behring today showed clinical efficacy of a once-weekly dosing regimen of recombinant fusion protein linking coagulation Factor IX
with albumin (rIX-FP).
Tenders are invited for Acquisition of Coagulation Factor IX
AMSTERDAM, July 3, 2013 /PRNewswire/ -- CSL Behring today presented a population pharmacokinetic model for recombinant fusion protein linking coagulation factor IX
with albumin (rIX-FP) at the International Society on Thrombosis and Haemostasis (ISTH) congress in Amsterdam.
Hemophilia B (Christmas disease) is a rare, potentially life threatening, congenital bleeding disorder resulting from a defect or deficiency in blood coagulation factor IX
Human Coagulation Factor Ix
4 600 Iu Vial Lyophilized Lot.
Efficacy, PK and Safety Results of a Phase I/II Clinical Trial of Recombinant Fusion Protein Linking Coagulation Factor IX
with Albumin (rIX-FP) in Previously Treated Patients with Hemophilia B (PROLONG - 9FP)(U.